Stockreport

Lineage Cell Therapeutics Awarded NIH Grant for Innovative Vision Restoration Program

Lineage Cell Therapeutics, Inc.  (LCTX) 
PDF CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell thera [Read more]